Assay for PIK3CA mutations in cfDNA and concordance of cfDNA mutation status with tumor mutation status in breast cancer

Disease:

Study phase:

Not applicable

Physician name:

Funda Meric-Bernstam

Department:

Investigational Cancer Therapeutics

For general questions about clinical trials:

1-833-875-0030